Anna Prizment joins our faculty as an associate professor effective March 1. She comes to LMP from the Department of Medicine's Division of Hematology, Oncology and Transplantation.

Prizment earned her master's and doctoral degrees from the University of Minnesota. She was a University postdoctoral fellow in the field of "Nutrition and Cancer." From 2013-2019 Prizment was assistant professor in the Division of Epidemiology and Community Health, School of Public Health. She is a member of the Masonic Cancer Center and the Graduate Faculty in Epidemiology PhD Program.

As a cancer epidemiologist, Prizment studies cancer prevention and survival of cancer patients, and with her research focused on two closely related areas. The first is the role of inflammation and immune response, as measured by circulating and tissue biomarkers, genetic alterations and gut microbiome, in gastrointestinal cancers. The second focus of her research is on the role of aspirin and other anti-inflammatory agents in colorectal cancer. Although most of her studies are in gastrointestinal cancers, she is also interested in studying other types of cancer (e.g. prostate, breast) including risk factors for their development and survival.

Zhou, B., Lu, J., Beck, J. D., Moss, K. L., Prizment, A. E., Demmer, R. T., Porosnicu Rodriguez, K. A., Joshu, C. E., Michaud, D. S., & Platz, E. A. (2022). Periodontal and other oral bacteria and risk of lung cancer in the Atherosclerosis Risk in Communities (ARIC) Study. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. PMID: 35999656 doi: 10.1158/1055-9965.EPI-22-0601

Hurwitz, L. M., Townsend, M. K., J.... Prizment, A., Schildkraut, J. M.,.. White, E., Peters, U., Webb, P. M., Tworoger, S. S., & Trabert, B. (2022). Modification of the association between frequent aspirin use and ovarian cancer risk: A meta-analysis using individual-level data from two ovarian cancer consortia. Journal of clinical oncology: official journal of the American Society of Clinical Oncology, JCO2101900. PMID: 35867953 doi: 10.1200/JCO.21.01900

Bhatia, R., Holtan, S., Jurdi, N. E., Prizment, A., & Blaes, A. (2022). Do cancer and cancer treatments accelerate aging? Current oncology reports. PMID: 35796942 doi: 10.1007/s11912-022-01311-2

Florido, R., Daya, N. R., Ndumele, C. E., Koton, S., Russell, S. D., Prizment, A., Blumenthal, R. S., Matsushita, K., Mok, Y., Felix, A. S., Coresh, J., Joshu, C. E., Platz, E. A., & Selvin, E. (2022). Cardiovascular disease risk among cancer survivors: The Atherosclerosis Risk In Communities (ARIC) Study. Journal of the American College of Cardiology, 80(1), 22-32. PMID: 35772913 doi: 10.1016/j.jacc.2022.04.042